Breaking Barriers to Precision Oncology Implementation with Digital Solutions
Healthcare Transformers – 17 May 2023
Ming Huang-Chen, Henning Schulze-Bergkamen, Anthony Magliocco, Albino Troilo
Read an excerpt from the article below, or the full article on HealthcareTransformers: https://healthcaretransformers.com/digital-health/precision-oncology-digital-solutions/
The life-saving potential of precision oncology
“My son is eighteen years old. They told me they cured his testicular cancer and not to worry about it. But it’s come back. Now it’s in his liver and his bones, and it looks like he’s dying. He can barely breathe. It’s growing so fast, and they can’t do anything. Is there something you can do to help?”
Dr. Anthony Magliocco, Professor of Pathology at University of Central Florida and precision oncology expert, received the above call from the mother of a cancer patient in Australia. Dr. Magliocco requested the patient’s molecular testing results, only to learn that molecular testing was never performed.
After weeks of jumping through hoops to collect samples from the patient, Dr. Magliocco performed a next-generation sequencing (NGS) analysis of the tumor sample and, with the support of specific digital solutions, was able to quickly identify several actionable genomic mutations and four clinical trial options that would be suitable for the patient.
The patient’s doctor in Australia needed to be convinced about the novel treatment options, initially suspecting Dr. Magliocco to be “an unreputable doctor in America.” The two doctors spoke and conducted a virtual tumor board to review the detailed results, and eventually, the patient was enrolled in a clinical trial in France.
Six months later, the patient’s mother called Dr. Magliocco with an update. “We went for a scan last week, and he’s totally cancer free. The cancer’s completely gone. It’s just nothing. None of it’s left at all. And he’s back at college, playing sports again, and it’s just a miraculous cure.”
Overjoyed at the news, Dr. Magliocco shared that all he did was what he believed should be the standard for every patient. Precision oncology made possible this young Australian patient’s positive outcome. It is a paradigm shift in cancer treatment that not only improves patient outcomes and alters the trajectory of their illness, but also saves them from unnecessary toxicity and reduces healthcare costs from unneeded treatments.
In spite of these benefits, precision oncology continues to be a privilege to which a select few have access.
For further information, please contact:
Anthony Magliocco MD
CEO & President of Protean BioDiagnostics
Email: info@proteanbiodx.com
Phone: 1 (813) 817 2042